02Mar 2023
A narrative review of epidemiological characteristics and management of nonalcoholic fatty liver disease/nonalcoholic steatohepatitis in China

A narrative review of epidemiological characteristics and management of nonalcoholic fatty liver disease/nonalcoholic steatohepatitis in China

The researchers searched English and Chinese databases comprehensively and summarized the epidemiological studies of non-alcoholic fatty liver disease (NAFLD)/non-alcoholic steatohepatitis (NASH) in China. They found that the prevalence of NAFLD in China is nearly 30% of the general population, which is twice as high as that in western countries, and it is the leading cause of chronic liver disease. The prevalence varies among provinces/regions, age groups, sexes, and individuals with different metabolic profiles. They also noted that many Chinese patients with chronic hepatitis B also have NAFLD. This review highlights Chinese scholars' efforts to achieve optimal disease management, including lifestyle interventions, antidiabetic drugs, traditional Chinese medicines, and innovative targeted therapies developed in China.

  • #endo-diabetology

Like

Save

Share